Point72 Asset Management, L.P. 13D/13G Filings for Allena Pharmaceuticals, Inc. (ALNAQ)

Point72 Asset Management, L.P. 13D and 13G filings for Allena Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
4:34 pm
Sale
2021-12-3113GAllena Pharmaceuticals, Inc.
ALNAQ
Point72 Asset Management, L.P.0
0.000%
-4,000,000decrease
(Position Closed)
Filing
2020-12-10
5:10 pm
Purchase
2020-12-0413GAllena Pharmaceuticals, Inc.
ALNAQ
Point72 Asset Management, L.P.4,000,000
8.000%
4,000,000increase
(New Position)
Filing